Individualised approach to care reduces overtreatment of type 2 diabetes mellitus in frail older people
Intensive treatment with insulin and sulfonylureas in older people with low HbA1c (<53mmol/mol) can increase the risk of hypoglycaemia, morbidity and mortality. Older people are less likely to benefit from the long-term protective effects of good glycaemic control and are at risk of inappropriate…